Enhancing Attention and Wellbeing Using Digital Therapeutics

Recruiting N/A Interventional Study
Aging MCI Cognitive Decline
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
60 – 99
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
4,000 (estimated)
Sponsor
University of California, San Francisco · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goals of the proposed research are to first determine the minimal and/or optimal dose of a digital intervention required for cognitive enhancement, and then to examine the impact of several potential moderators of treatment effects (i.e., cognitive decline, AD polygenic hazard score, cardiovascular risk, and race/ethnicity). This knowledge gained from his high-impact study with transform the f…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 60+ years old (adult) * English language fluency * owning a smartphone or tablet Exclusion Criteria: * Under 60 years old (minor)
Contacts

David Ziegler, PhD

4154762164

david.ziegler@ucsf.edu

CONTACT

Monique de Villa, MS, MPH

209-233-3878

meditrain@ucsf.edu

CONTACT